Last reviewed · How we verify

NCT03886584

Source Monitoring Déficit in Neuropsychiatric Population

Recruiting now NA Last updated 31 July 2025
What this trial tests

NA trial testing Monitoring source test in Psychiatric Disorder in 300 participants. Currently enrolling.

Timeline
8 March 2019
Primary endpoint
8 March 2026
31 July 2026

Quick facts

Lead sponsorHôpital le Vinatier
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment300
Start date8 March 2019
Primary completion8 March 2026
Estimated completion31 July 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hôpital le Vinatier — full company profile →

Who can join

Adults 18 to 80, any sex, with Psychiatric Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the investigators will measure source-monitoring ability in patients with several neuropsychiatric condition and in healthy controls appaired in age, sex and educational level. Source-monitoring will be measured thanks to internal- and reality-monitoring informatic tasks.The investigators hypothesized patients with fronto-temporal abnormalities would show more marked deficits than patients with only frontal abnormalities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Psychiatric Disorder

Currently open trials in the same condition.

Other Hôpital le Vinatier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03886584.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing